Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VT-1161 in moderate to severe interdigital tinea pedis
NCT01891305Phase 2Completed
- Sponsor
- Viamet Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oteseconazole in tinea pedis, sponsored by Viamet Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
oteseconazole
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT01891305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01891305.